Press Releases

The global surgical site infection prevention market was valued at USD 4.2 billion in 2023 and is anticipated to reach to USD 7.5 billion by 2030, registering a CAGR of 6.8% during the forecast period 2025-2030. Factors attributing to the growth of the surgical site infection prevention market include the rising prominence of SSIs, rising number of surgical procedures, technological development of innovating new products, a significant increase in the occurrence of complications from HAIs, and rising geriatric population. Nevertheless, the growing initiatives by the government and rising number of collaborations by key industry players will create opportunities for growth of the surgical site infection prevention market.

3M is on the mission to protect patients from preventable surgical site infections (SSIs) as they believe that up to 5% of patients undergoing surgery may have negative consequences of an SSI, as patients might have an increased length of stay in hospital that can impact the quality of life. So they are committed to using their best practices and evidence-based solutions to reduce the risk of SSIs in the facility

The COVID-19 outbreak has had a negative impact on surgical site infection prevention market owing to decrease in funding of R&D activities associated with surgical site infection control agents and decrease in number of elective surgeries will adversely affect the market.

Browse 53 market data Tables and 35 Figures spread through 200 Pages and in-depth TOC on " Surgical Site Infection Prevention Market by Product (Wound Care Dressings, Antibiotic Prophylaxis, Clippers, Surgical Drapes, Antiseptics and Disinfectants, Surgical Staff Clothing, Patient-Warming Products, Wound Irrigation Products, Wound Care Supplementary Products and Others), by Phases (Postoperative, Preoperative and Intraoperative), and by End User (Ambulatory Surgery Centers, Hospitals, Clinics and Others), and Region - Global Forecast to 2030"

By product, antibiotic prophylaxis contributes to the largest share in the Surgical Site Infection Prevention Market in 2023.

Based on product, the surgical site infection prevention market is segmented into wound care dressings, antibiotic prophylaxis products, clippers, surgical drapes, antiseptics and disinfectants, surgical staff clothing, patient-warming products, wound irrigation products, wound care supplementary products and others. The antibiotic prophylaxis dominate the market owing to the increased cost of antibiotics, acceptance of antibiotics as most established preventive method for surgical site infections and patient friendly dosage forms like tablets, capsules, etc.

Global Surgical Site Infection Prevention Market Segmentation and Key Players

Discover More About This Report, Download A Free Sample Copy of Global Surgical Site Infection Prevention Market

“Asia-Pacific is anticipated to be the fastest growing region in the Surgical Site Infection Prevention Market during 2025-2030.”

Asia-Pacific is expected to be the fastest-growing region in the Surgical Site Infection Prevention Market owing to increasing patient pool, increased awareness by government organizations, abd rising prominence of surgical site infections.

Some of the major players in the surgical site infection prevention market include 3M Company, Medtronic plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Covalon Technologies Ltd., Stryker Corporation, Becton, Dickinson and Company, Prescient Surgical Inc., Surgical Site Infection Prevention LLC, and STERIS plc.

Global Surgical Site Infection Prevention Market Coverage

Product Insight and Forecast 2025-2030

• Wound Care Dressings
• Antibiotic Prophylaxis
• Clippers
• Surgical Drapes
• Antiseptics and Disinfectants
• Surgical Staff Clothing
• Patient-Warming Products
• Wound Irrigation Products
• Wound Care Supplementary Products
• Others

Phases Insight and Forecast 2025-2030

• Postoperative
• Preoperative an
• Intraoperative

End User Insight and Forecast 2025-2030

• Ambulatory Surgery Centers
• Hospitals
• Clinics
• Others

Geographical Segmentation

Surgical Site Infection Prevention Market Market by Region

North America

• By Product
• By Phases
• By End User
• By Country – U.S., Canada, and Mexico

Europe

• By Product
• By Phases
• By End User
• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Product
• By Phases
• By End User
• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Product
• By Phases
• By End User
• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries